Skip Navigation Links

Merck | Company Information from ICIS

 

Merck is a global health care provider with a portfolio of prescription medicines, vaccines and animal and consumer health products. In November 2009, Merck & Co and Schering-Plough completed its planned merger. The merged companies will operate under the Merck name.

 

Merck's product line includes a broad portfolio of prescription products in important therapeutic areas. Human health products include medicines to help treat high blood pressure, congestive heart failure, elevated cholesterol levels, osteoporosis, benign prostatic hyperplasia, arthritis, pain, migraine, glaucoma, gastrointestinal ulcers, emesis, antibiotic, antifungal and antiviral agents, and vaccines to help prevent childhood diseases, pneumonia and hepatitis A and B.

 

Merck will continue with its ongoing strategy titled “Merck's Plan to Win” to achieve $3.5bn-$4bn in pre-tax savings by 2010.

 

Since its merger with Schering-Plough, Merck has approximately 106,000 employees and operates in more than 140 countries around the world, including emerging markets.

 

Its corporate headquarters are in Whitehouse Station, New Jersey, US.

 

ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.

 

A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.

 

See the article and analysis of the ICIS Top 100 on ICIS news.

 

Key Personnel

 

Chief executive officer: Richard Clark

Chief financial officer: Peter Kellogg

Chief compliance officer: Richard Bowles

Chief information officer (Global Services): J. Chris Scalet

Chief strategy officer: Mervyn Turner

Executive VP and president (Consumer Health Care): Stanley Barshay

Executive VP and president (Merck Manufacturing): Willie Deese

Executive VP and president (Global Human Health): Kenneth Frazier

Executive VP (HR): Mirian Graddick-Weir

Executive VP and president (Merck Research Laboratories): Peter Kim

President (Animal Health): Raul Kohan

General counsel: Bruce Kuhlik

 

(Updated November 2009)

 

Contacts


1 Merck Drive
PO Box 100

Whitehouse Station
New Jersey 08889
US

Tel: +1 908 423 1000

 

www.merck.com 

Merck Company Structure

Merck is a global health care provider with a portfolio of prescription medicines, vaccines and animal and consumer health products. In November 2009, Merck & Co and Schering-Plough completed its planned merger. The merged companies will operate under the Merck name.
More about Merck Structure

Merck Strategy & Financial Highlights

In August 2009, Schering-Plough approved the merger with Merck & Co. It is believed that by combining the two companies it will create a “strong global health care leader”. Under the name “Merck”, the combined company will be headed by Merck chairman, president and chief executive officer, Richard Clark and have headquarters in Whitehouse Station, New Jersey, US. More about Merck Strategy & Financial Highlights

News:

Get news on Merck plus the latest chemical news, information, data, market movements and analysis in one place with ICIS news

Search:

Find details on other chemical companies and suppliers with ICIS search

Newsletters:

ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.

Plants and projects:

Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database

 
Free trial to ICIS
Paul Hodges - Chemicals & the Economy Blog
Paul Hodges looks behind today's headlines and studies key influencers shaping the chemical industry over the next 12-18 months. He takes a closer look at oil prices, economic growth and the environment among other things, along with some light-hearted banter along the way.

Insight

INSIGHT: Enjoy China’s chemicals imports while they last
“When economic stimulus shifts away from supporting exports, chemicals import volumes will slip.” more

VIDEO - ICIS news Asia Lunchtime Bulletin 9 November 2009

More...

We welcome your feedback. Please feel free to send us your comments on any aspect of this site. Click here to make your comments.